{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:26:50Z","timestamp":1775129210549,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100005191","name":"Craig H. Neilsen Foundation","doi-asserted-by":"publisher","award":["297267"],"award-info":[{"award-number":["297267"]}],"id":[{"id":"10.13039\/100005191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00198-023-06679-w","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T11:03:24Z","timestamp":1675422204000},"page":"741-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of lower extremity bone mineral density 1\u00a0year after denosumab is discontinued in persons with subacute spinal cord injury"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-5067","authenticated-orcid":false,"given":"Christopher M.","family":"Cirnigliaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"La Fountaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Scott","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Kirshblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue A.","family":"Shapses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa A.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"issue":"1","key":"6679_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00198-013-2419-1","volume":"25","author":"D Lala","year":"2014","unstructured":"Lala D, Craven BC, Thabane L, Papaioannou A, Adachi JD, Popovic MR et al (2014) Exploring the determinants of fracture risk among individuals with spinal cord injury. Osteoporos Int 25(1):177\u2013185","journal-title":"Osteoporos Int"},{"issue":"2","key":"6679_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jocd.2018.10.006","volume":"22","author":"CM Cirnigliaro","year":"2019","unstructured":"Cirnigliaro CM, Myslinski MJ, Asselin P, Hobson JC, Specht A, La Fountaine MF et al (2019) Progressive sublesional bone loss extends into the second decade after spinal cord injury. J Clin Densitom 22(2):185\u201394","journal-title":"J Clin Densitom"},{"key":"6679_CR3","doi-asserted-by":"publisher","first-page":"106102","DOI":"10.1016\/j.cct.2020.106102","volume":"96","author":"AM Spungen","year":"2020","unstructured":"Spungen AM, Bauman WA, Biswas K, Jones KM, Snodgrass AJ, Goetz LL et al (2020) The design of a randomized control trial of exoskeletal-assisted walking in the home and community on quality of life in persons with chronic spinal cord injury. Contemp Clin Trials 96:106102","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"6679_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"issue":"1","key":"6679_CR5","doi-asserted-by":"publisher","first-page":"rkaa008","DOI":"10.1093\/rap\/rkaa008","volume":"4","author":"Y Yamaguchi","year":"2020","unstructured":"Yamaguchi Y, Morita T, Kumanogoh A (2020) The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis. Rheumatol Adv Pract 4(1):rkaa008","journal-title":"Rheumatol Adv Pract"},{"key":"6679_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41393-020-0431-9","volume":"58","author":"CV Oleson","year":"2020","unstructured":"Oleson CV, Marino RJ, Formal CS, Modlesky CM, Leiby BE (2020) The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study. Spinal Cord 58:921","journal-title":"Spinal Cord"},{"issue":"4","key":"6679_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","volume":"33","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cirnigliaro CM, La Fountaine MF, Martinez L, Kirshblum SC, Spungen AM (2015) Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study. J Bone Miner Metab 33(4):410\u2013421","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"6679_CR8","doi-asserted-by":"publisher","first-page":"e10375","DOI":"10.1002\/jbm4.10375","volume":"4","author":"CM Cirnigliaro","year":"2020","unstructured":"Cirnigliaro CM, La Fountaine MF, Parrott JS, Kirshblum SC, McKenna C, Sauer SJ et al (2020) Administration of denosumab preserves bone mineral density at the knee in persons with subacute spinal cord injury: findings from a randomized clinical trial. JBMR Plus 4(8):e10375","journal-title":"JBMR Plus"},{"issue":"5","key":"6679_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","volume":"28","author":"MR McClung","year":"2017","unstructured":"McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM (2017) Observations following discontinuation of long-term denosumab therapy. Osteoporos Int 28(5):1723\u20131732","journal-title":"Osteoporos Int"},{"issue":"1","key":"6679_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00198-017-4242-6","volume":"29","author":"MB Zanchetta","year":"2018","unstructured":"Zanchetta MB, Boailchuk J, Massari F, Silveira F, Bogado C, Zanchetta JR (2018) Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study. Osteoporos Int 29(1):41\u201347","journal-title":"Osteoporos Int"},{"key":"6679_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D (2013) Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol 4:863","journal-title":"Front Psychol"},{"issue":"3","key":"6679_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10790268.2004.11753749","volume":"27","author":"DE Garland","year":"2004","unstructured":"Garland DE, Adkins RH, Scott M, Singh H, Massih M, Stewart C (2004) Bone loss at the os calcis compared with bone loss at the knee in individuals with spinal cord injury. J Spinal Cord Med 27(3):207\u2013211","journal-title":"J Spinal Cord Med"},{"issue":"3","key":"6679_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00198-016-3841-y","volume":"28","author":"L Abderhalden","year":"2017","unstructured":"Abderhalden L, Weaver FM, Bethel M, Demirtas H, Burns S, Svircev J et al (2017) Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders. Osteoporos Int 28(3):925\u2013934","journal-title":"Osteoporos Int"},{"issue":"4","key":"6679_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41393-019-0383-0","volume":"58","author":"A Frotzler","year":"2020","unstructured":"Frotzler A, Krebs J, Gohring A, Hartmann K, Tesini S, Lippuner K (2020) Osteoporosis in the lower extremities in chronic spinal cord injury. Spinal Cord 58(4):441\u2013448","journal-title":"Spinal Cord"},{"issue":"2","key":"6679_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2340\/16501977-0499","volume":"42","author":"CH Lai","year":"2010","unstructured":"Lai CH, Chang WH, Chan WP, Peng CW, Shen LK, Chen JJ et al (2010) Effects of functional electrical stimulation cycling exercise on bone mineral density loss in the early stages of spinal cord injury. J Rehabil Med 42(2):150\u2013154","journal-title":"J Rehabil Med"},{"issue":"9","key":"6679_CR16","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00198-011-1879-4","volume":"23","author":"S Dudley-Javoroski","year":"2012","unstructured":"Dudley-Javoroski S, Saha PK, Liang G, Li C, Gao Z, Shields RK (2012) High dose compressive loads attenuate bone mineral loss in humans with spinal cord injury. Osteoporos Int 23(9):2335\u20132346","journal-title":"Osteoporos Int"},{"issue":"1","key":"6679_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2008.03.004","volume":"43","author":"A Frotzler","year":"2008","unstructured":"Frotzler A, Coupaud S, Perret C, Kakebeeke TH, Hunt KJ, Donaldson Nde N et al (2008) High-volume FES-cycling partially reverses bone loss in people with chronic spinal cord injury. Bone 43(1):169\u2013176","journal-title":"Bone"},{"issue":"22","key":"6679_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/09638280500164032","volume":"27","author":"SC Chen","year":"2005","unstructured":"Chen SC, Lai CH, Chan WP, Huang MH, Tsai HW, Chen JJ (2005) Increases in bone mineral density after functional electrical stimulation cycling exercises in spinal cord injured patients. Disabil Rehabil 27(22):1337\u20131341","journal-title":"Disabil Rehabil"},{"issue":"2","key":"6679_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190\u2013198","journal-title":"J Bone Miner Res"},{"issue":"1","key":"6679_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/jcm10010152","volume":"10","author":"AD Anastasilakis","year":"2021","unstructured":"Anastasilakis AD, Makras P, Yavropoulou MP, Tabacco G, Naciu AM, Palermo A (2021) Denosumab discontinuation and the rebound phenomenon: a narrative review. J Clin Med 10(1):152","journal-title":"J Clin Med"},{"issue":"2","key":"6679_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3803\/EnM.2021.1369","volume":"37","author":"WL Tay","year":"2022","unstructured":"Tay WL, Tay D (2022) Discontinuing denosumab: can it be done safely? A review of the literature. Endocrinol Metab (Seoul) 37(2):183\u2013194","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"6679_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00198-003-1529-6","volume":"15","author":"Y Zehnder","year":"2004","unstructured":"Zehnder Y, Luthi M, Michel D, Knecht H, Perrelet R, Neto I et al (2004) Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men. Osteoporos Int 15(3):180\u2013189","journal-title":"Osteoporos Int"},{"issue":"1","key":"6679_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, Kaur P, Macarios D, Siddhanti S et al (2012) Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23(1):317\u2013326","journal-title":"Osteoporos Int"},{"issue":"1","key":"6679_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00223-018-0404-6","volume":"103","author":"AM Horne","year":"2018","unstructured":"Horne AM, Mihov B, Reid IR (2018) Bone loss after romosozumab\/denosumab: effects of bisphosphonates. Calcif Tissue Int 103(1):55\u201361","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"6679_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00774-020-01126-w","volume":"38","author":"H Kondo","year":"2020","unstructured":"Kondo H, Okimoto N, Yoshioka T, Akahoshi S, Fuse Y, Ogawa T et al (2020) Zoledronic acid sequential therapy could avoid disadvantages due to the discontinuation of less than 3-year denosumab treatment. J Bone Miner Metab 38(6):894\u2013902","journal-title":"J Bone Miner Metab"},{"issue":"9999","key":"6679_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM et al (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 386(9999):1147\u20131155","journal-title":"Lancet"},{"issue":"12","key":"6679_CR27","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s00198-019-05146-9","volume":"30","author":"DL Kendler","year":"2019","unstructured":"Kendler DL, Bone HG, Massari F, Gielen E, Palacios S, Maddox J et al (2019) Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab. Osteoporos Int 30(12):2437\u20132448","journal-title":"Osteoporos Int"},{"issue":"1","key":"6679_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FR, Ferguson-Pell M, Swaminathan R, Keen RW (2011) Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int 22(1):271\u2013279","journal-title":"Osteoporos Int"},{"issue":"12","key":"6679_CR29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41393-018-0195-7","volume":"56","author":"S Goenka","year":"2018","unstructured":"Goenka S, Sethi S, Pandey N, Joshi M, Jindal R (2018) Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial. Spinal Cord 56(12):1207\u20131211","journal-title":"Spinal Cord"},{"issue":"1\u20132","key":"6679_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1615\/CritRevPhysRehabilMed.2016018768","volume":"28","author":"SM Varghese","year":"2016","unstructured":"Varghese SM, Bobeena RC, Raji T, Tharion J (2016) Effect of zoledronic acid on osteoporosis after chronic spinal cord injury. Crit Rev Phys Rehabil Med 28(1\u20132):85\u201393","journal-title":"Crit Rev Phys Rehabil Med"},{"key":"6679_CR31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.pmrj.2016.01.012","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D (2016) Zoledronic acid treatment after acute spinal cord injury: results of a randomized, placebo-controlled pilot trial. PM R 8:833","journal-title":"PM R"},{"issue":"1","key":"6679_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00223-018-0394-4","volume":"103","author":"AW Popp","year":"2018","unstructured":"Popp AW, Varathan N, Buffat H, Senn C, Perrelet R, Lippuner K (2018) Bone mineral density changes after 1 year of denosumab discontinuation in postmenopausal women with long-term denosumab treatment for osteoporosis. Calcif Tissue Int 103(1):50\u201354","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"6679_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.apmr.2020.07.018","volume":"102","author":"P Asselin","year":"2021","unstructured":"Asselin P, Cirnigliaro CM, Kornfeld S, Knezevic S, Lackow R, Elliott M et al (2021) Effect of exoskeletal-assisted walking on soft tissue body composition in persons with spinal cord injury. Arch Phys Med Rehabil 102(2):196\u2013202","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"6679_CR34","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/10790268.2017.1314900","volume":"41","author":"A Ramanujam","year":"2018","unstructured":"Ramanujam A, Cirnigliaro CM, Garbarini E, Asselin P, Pilkar R, Forrest GF (2018) Neuromechanical adaptations during a robotic powered exoskeleton assisted walking session. J Spinal Cord Med 41(5):518\u2013528","journal-title":"J Spinal Cord Med"},{"issue":"2","key":"6679_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.apmr.2020.08.025","volume":"102","author":"S Knezevic","year":"2021","unstructured":"Knezevic S, Asselin PK, Cirnigliaro CM, Kornfeld S, Emmons RR, Spungen AM (2021) Oxygen uptake during exoskeletal-assisted walking in persons with paraplegia. Arch Phys Med Rehabil 102(2):185\u2013195","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"6679_CR36","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/jbmr.4098","volume":"35","author":"AS Solling","year":"2020","unstructured":"Solling AS, Harslof T, Langdahl B (2020) Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial. J Bone Miner Res 35(10):1858\u20131870","journal-title":"J Bone Miner Res"},{"issue":"4","key":"6679_CR37","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1210\/jc.2010-1502","volume":"96","author":"HG Bone","year":"2011","unstructured":"Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang YC et al (2011) Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab 96(4):972\u2013980","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06679-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06679-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T08:05:47Z","timestamp":1679990747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06679-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["6679"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06679-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Christopher M. Cirnigliaro, Michael F. La Fountaine, J. Scott Parrott, \nSteven C. Kirshblum, Susan J.\u00a0Sauer, Sue A.\u00a0Shapses, Isa A. McClure, and William A. Bauman declare \nthat they have no conflicts of interest to report","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}